• Medicine
  • Published 2009

A method for treating prostate cancer antagonist gonadotropin releasing Harmon (gnrh) degarelix

@inproceedings{2009AMF,
  title={A method for treating prostate cancer antagonist gonadotropin releasing Harmon (gnrh) degarelix},
  author={Тин Колд Олесен and Бо-Эрик Перссон and Пер Кантор and Дер Мулен Эгберт А. Ван and Йенс-Кристиан Слотт Йенсен},
  year={2009}
}
1. A composition comprising degarelix (degarelix), for treatment in a subject of prostate cancer, which provides a reduced incidence and / or likelihood of a side effect other than the side effect associated with the injection site. ! 2. The composition of claim 1 for treating a subject for prostate cancer providing a reduced incidence and / or likelihood of a side effect other than the side effect associated with the administration site. ! 3. The composition of claim 1 or 2 for the… CONTINUE READING

Topics from this paper.